Securing the diagnosis of HRS-AKI: implications for current therapies-Reference-Cited by-同舟云学术

Securing the diagnosis of HRS-AKI: implications for current therapies

Published:2023-11-22 Issue:12 Volume:17 Page:1233-1239
ISSN:1747-4124
Container-title:Expert Review of Gastroenterology & Hepatology
language:en
Short-container-title:Expert Review of Gastroenterology & Hepatology

Author:

Mohanty Arpan¹,Cárdenas Andrés²

Affiliation:

1. Boston University Chobanian and Avedisian School of Medicine and Boston Medical Center, United States

2. GI and Liver Unit, Institut de Malalties Digestives, Hospital Clinic, Institut d’Investigacions Biomèdiques August Pi-Sunyer (IDIBAPS), Barcelona and Ciber de Enfermedades Hepáticas y Digestivas (CIBEREHD), University of Barcelona, Barcelona, Spain

Funder

Instituto de Salud Carlos III and Plan Estatal de Investigación Ciéntifica y Técnica y de Innovación

Publisher

Informa UK Limited

Subject

Gastroenterology,Hepatology

Link

https://www.tandfonline.com/doi/pdf/10.1080/17474124.2023.2284189

Reference49 articles.

1. Terlipressin for hepatorenal syndrome: opportunities and challenges

2. Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases

3. Acute Kidney Injury in Patients with Cirrhosis

4. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis

5. Early treatment with terlipressin in patients with hepatorenal syndrome yields improved clinical outcomes in North American studies

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Terlipressin plus albumin in patients with HRS listed for liver transplant: Treat early and avoid RRT;Liver Transplantation;2023-12-18